首页|期刊导航|Oncology Research|Isoliquiritigenin Impedes Breast Cancer Progression through PITX1-PFKP-Mediated Glycolysis Reprogramming

Isoliquiritigenin Impedes Breast Cancer Progression through PITX1-PFKP-Mediated Glycolysis Reprogramming

Cong Liu Zhenyu Zhang Ronghua Feng Mengsi Zeng Hui Li Mei Zhu Lan Zhuang Zongjuan Li Tao Wu

Oncology Research2026，Vol.34Issue(5)：P.825-845,21.

Oncology Research2026，Vol.34Issue(5)：P.825-845,21.DOI:10.32604/or.2026.077059

Isoliquiritigenin Impedes Breast Cancer Progression through PITX1-PFKP-Mediated Glycolysis Reprogramming

Cong Liu ¹Zhenyu Zhang ¹Ronghua Feng ¹Mengsi Zeng ¹Hui Li ¹Mei Zhu ¹Lan Zhuang ²Zongjuan Li ¹Tao Wu¹

作者信息

1. Changde Hospital,Xiangya School of Medicine,Central South University(The First People’s Hospital of Changde City),Changde,China
2. University Hospital,Central South University,Changsha,China
折叠

摘要

关键词

Breast cancer/PITX1/PFKP/metastasis/glycolysis/isoliquiritigenin

分类

医药卫生

引用本文复制引用

Cong Liu,Zhenyu Zhang,Ronghua Feng,Mengsi Zeng,Hui Li,Mei Zhu,Lan Zhuang,Zongjuan Li,Tao Wu..Isoliquiritigenin Impedes Breast Cancer Progression through PITX1-PFKP-Mediated Glycolysis Reprogramming[J].Oncology Research,2026,34(5):P.825-845,21.

基金项目

funded by the Hunan Provincial Department of Science and Technology(2024JJ7023) （2024JJ7023）

the Project of Hunan Provincial Natural Science Foundation Regional Joint,and the Project of Wu Jieping Medical Foundation(No.320.6750.2024-12-141,Tao Wu). （No.320.6750.2024-12-141,Tao Wu）

Oncology Research

ISSN：0965-0407

访问量0

下载量0

段落导航